KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $161,000 | -10.6% | 10,418 | -15.5% | 0.00% | -100.0% |
Q3 2020 | $180,000 | -26.2% | 12,329 | -4.2% | 0.00% | 0.0% |
Q2 2020 | $244,000 | -6.5% | 12,866 | -5.3% | 0.00% | 0.0% |
Q1 2020 | $261,000 | +26.1% | 13,584 | +25.8% | 0.00% | 0.0% |
Q4 2019 | $207,000 | +762.5% | 10,802 | +174.4% | 0.00% | – |
Q2 2019 | $24,000 | -91.3% | 3,937 | -46.7% | 0.00% | -100.0% |
Q4 2014 | $276,000 | -61.3% | 7,381 | -63.9% | 0.00% | -70.0% |
Q3 2014 | $714,000 | – | 20,421 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |